Global Chorionic Gonadotrophin for Injection Market Research Report 2025(Status and Outlook)
Description
Report Overview
Chorionic Gonadotrophin for Injection (hCG) is a hormone derived from human placenta or produced through recombinant DNA technology, primarily used in fertility treatments to stimulate ovulation in women and testosterone production in men, as well as in certain cases of cryptorchidism (undescended testes) in pediatric patients. The market for hCG injections is driven by increasing infertility rates globally, advancements in assisted reproductive technologies (ART), and rising awareness about fertility treatments. Demand is further supported by the growing prevalence of hormonal disorders and the expansion of healthcare infrastructure in emerging markets. However, regulatory complexities, high treatment costs, and the availability of alternative therapies pose challenges. Key players in the market include pharmaceutical companies such as Merck, Ferring Pharmaceuticals, and Sanofi, competing through product innovation and strategic partnerships. The market is segmented by application (fertility treatment, testosterone stimulation, and others), source (natural and recombinant), and distribution channel (hospitals, fertility clinics, and retail pharmacies). North America and Europe dominate due to high adoption rates of ART, while the Asia-Pacific region is expected to witness significant growth due to improving healthcare access and increasing infertility cases.
The global Chorionic Gonadotrophin for Injection market size was estimated at USD 208.07 million in 2024, exhibiting a CAGR of 5.32% during the forecast period.
This report provides a deep insight into the global Chorionic Gonadotrophin for Injection market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Chorionic Gonadotrophin for Injection Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Chorionic Gonadotrophin for Injection market in any manner.
Global Chorionic Gonadotrophin for Injection Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Beijing Science Sun Pharmaceutical
Shenyang EverBright Pharmaceutical
Yantai Dongcheng Beifang Pharmaceutical
Livzon Pharmaceutical Group
Ningbo Renjian Pharmaceutical
Ma'anshan Fengyuan Pharmaceutical
Harbin High-Tech Group Baitian'er Pharmaceutical
Sinopharm
Besins Healthcare Benelux
Bristol Myers Squibb
Organon
Market Segmentation (by Type)
1000U/Piece
2000U/Piece
5000U/Piece
Market Segmentation (by Application)
Hospital Pharmacy
Retail Pharmacy
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Chorionic Gonadotrophin for Injection Market
Overview of the regional outlook of the Chorionic Gonadotrophin for Injection Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Chorionic Gonadotrophin for Injection Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Chorionic Gonadotrophin for Injection, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Chorionic Gonadotrophin for Injection (hCG) is a hormone derived from human placenta or produced through recombinant DNA technology, primarily used in fertility treatments to stimulate ovulation in women and testosterone production in men, as well as in certain cases of cryptorchidism (undescended testes) in pediatric patients. The market for hCG injections is driven by increasing infertility rates globally, advancements in assisted reproductive technologies (ART), and rising awareness about fertility treatments. Demand is further supported by the growing prevalence of hormonal disorders and the expansion of healthcare infrastructure in emerging markets. However, regulatory complexities, high treatment costs, and the availability of alternative therapies pose challenges. Key players in the market include pharmaceutical companies such as Merck, Ferring Pharmaceuticals, and Sanofi, competing through product innovation and strategic partnerships. The market is segmented by application (fertility treatment, testosterone stimulation, and others), source (natural and recombinant), and distribution channel (hospitals, fertility clinics, and retail pharmacies). North America and Europe dominate due to high adoption rates of ART, while the Asia-Pacific region is expected to witness significant growth due to improving healthcare access and increasing infertility cases.
The global Chorionic Gonadotrophin for Injection market size was estimated at USD 208.07 million in 2024, exhibiting a CAGR of 5.32% during the forecast period.
This report provides a deep insight into the global Chorionic Gonadotrophin for Injection market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Chorionic Gonadotrophin for Injection Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Chorionic Gonadotrophin for Injection market in any manner.
Global Chorionic Gonadotrophin for Injection Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Beijing Science Sun Pharmaceutical
Shenyang EverBright Pharmaceutical
Yantai Dongcheng Beifang Pharmaceutical
Livzon Pharmaceutical Group
Ningbo Renjian Pharmaceutical
Ma'anshan Fengyuan Pharmaceutical
Harbin High-Tech Group Baitian'er Pharmaceutical
Sinopharm
Besins Healthcare Benelux
Bristol Myers Squibb
Organon
Market Segmentation (by Type)
1000U/Piece
2000U/Piece
5000U/Piece
Market Segmentation (by Application)
Hospital Pharmacy
Retail Pharmacy
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Chorionic Gonadotrophin for Injection Market
Overview of the regional outlook of the Chorionic Gonadotrophin for Injection Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Chorionic Gonadotrophin for Injection Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Chorionic Gonadotrophin for Injection, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Table of Contents
153 Pages
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Chorionic Gonadotrophin for Injection
- 1.2 Key Market Segments
- 1.2.1 Chorionic Gonadotrophin for Injection Segment by Type
- 1.2.2 Chorionic Gonadotrophin for Injection Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Chorionic Gonadotrophin for Injection Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Chorionic Gonadotrophin for Injection Market Size (M USD) Estimates and Forecasts (2020-2033)
- 2.1.2 Global Chorionic Gonadotrophin for Injection Sales Estimates and Forecasts (2020-2033)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Chorionic Gonadotrophin for Injection Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Chorionic Gonadotrophin for Injection Product Life Cycle
- 3.3 Global Chorionic Gonadotrophin for Injection Sales by Manufacturers (2020-2025)
- 3.4 Global Chorionic Gonadotrophin for Injection Revenue Market Share by Manufacturers (2020-2025)
- 3.5 Chorionic Gonadotrophin for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global Chorionic Gonadotrophin for Injection Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
- 3.8 Chorionic Gonadotrophin for Injection Market Competitive Situation and Trends
- 3.8.1 Chorionic Gonadotrophin for Injection Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest Chorionic Gonadotrophin for Injection Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Chorionic Gonadotrophin for Injection Industry Chain Analysis
- 4.1 Chorionic Gonadotrophin for Injection Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Chorionic Gonadotrophin for Injection Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Chorionic Gonadotrophin for Injection Market Porter's Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions and Their Impacts to Chorionic Gonadotrophin for Injection Market
- 5.7 ESG Ratings of Leading Companies
- 6 Chorionic Gonadotrophin for Injection Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Chorionic Gonadotrophin for Injection Sales Market Share by Type (2020-2025)
- 6.3 Global Chorionic Gonadotrophin for Injection Market Size Market Share by Type (2020-2025)
- 6.4 Global Chorionic Gonadotrophin for Injection Price by Type (2020-2025)
- 7 Chorionic Gonadotrophin for Injection Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Chorionic Gonadotrophin for Injection Market Sales by Application (2020-2025)
- 7.3 Global Chorionic Gonadotrophin for Injection Market Size (M USD) by Application (2020-2025)
- 7.4 Global Chorionic Gonadotrophin for Injection Sales Growth Rate by Application (2020-2025)
- 8 Chorionic Gonadotrophin for Injection Market Sales by Region
- 8.1 Global Chorionic Gonadotrophin for Injection Sales by Region
- 8.1.1 Global Chorionic Gonadotrophin for Injection Sales by Region
- 8.1.2 Global Chorionic Gonadotrophin for Injection Sales Market Share by Region
- 8.2 Global Chorionic Gonadotrophin for Injection Market Size by Region
- 8.2.1 Global Chorionic Gonadotrophin for Injection Market Size by Region
- 8.2.2 Global Chorionic Gonadotrophin for Injection Market Size Market Share by Region
- 8.3 North America
- 8.3.1 North America Chorionic Gonadotrophin for Injection Sales by Country
- 8.3.2 North America Chorionic Gonadotrophin for Injection Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Chorionic Gonadotrophin for Injection Sales by Country
- 8.4.2 Europe Chorionic Gonadotrophin for Injection Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Chorionic Gonadotrophin for Injection Sales by Region
- 8.5.2 Asia Pacific Chorionic Gonadotrophin for Injection Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Chorionic Gonadotrophin for Injection Sales by Country
- 8.6.2 South America Chorionic Gonadotrophin for Injection Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa Chorionic Gonadotrophin for Injection Sales by Region
- 8.7.2 Middle East and Africa Chorionic Gonadotrophin for Injection Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 9 Chorionic Gonadotrophin for Injection Market Production by Region
- 9.1 Global Production of Chorionic Gonadotrophin for Injection by Region(2020-2025)
- 9.2 Global Chorionic Gonadotrophin for Injection Revenue Market Share by Region (2020-2025)
- 9.3 Global Chorionic Gonadotrophin for Injection Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America Chorionic Gonadotrophin for Injection Production
- 9.4.1 North America Chorionic Gonadotrophin for Injection Production Growth Rate (2020-2025)
- 9.4.2 North America Chorionic Gonadotrophin for Injection Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe Chorionic Gonadotrophin for Injection Production
- 9.5.1 Europe Chorionic Gonadotrophin for Injection Production Growth Rate (2020-2025)
- 9.5.2 Europe Chorionic Gonadotrophin for Injection Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan Chorionic Gonadotrophin for Injection Production (2020-2025)
- 9.6.1 Japan Chorionic Gonadotrophin for Injection Production Growth Rate (2020-2025)
- 9.6.2 Japan Chorionic Gonadotrophin for Injection Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China Chorionic Gonadotrophin for Injection Production (2020-2025)
- 9.7.1 China Chorionic Gonadotrophin for Injection Production Growth Rate (2020-2025)
- 9.7.2 China Chorionic Gonadotrophin for Injection Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Beijing Science Sun Pharmaceutical
- 10.1.1 Beijing Science Sun Pharmaceutical Basic Information
- 10.1.2 Beijing Science Sun Pharmaceutical Chorionic Gonadotrophin for Injection Product Overview
- 10.1.3 Beijing Science Sun Pharmaceutical Chorionic Gonadotrophin for Injection Product Market Performance
- 10.1.4 Beijing Science Sun Pharmaceutical Business Overview
- 10.1.5 Beijing Science Sun Pharmaceutical SWOT Analysis
- 10.1.6 Beijing Science Sun Pharmaceutical Recent Developments
- 10.2 Shenyang EverBright Pharmaceutical
- 10.2.1 Shenyang EverBright Pharmaceutical Basic Information
- 10.2.2 Shenyang EverBright Pharmaceutical Chorionic Gonadotrophin for Injection Product Overview
- 10.2.3 Shenyang EverBright Pharmaceutical Chorionic Gonadotrophin for Injection Product Market Performance
- 10.2.4 Shenyang EverBright Pharmaceutical Business Overview
- 10.2.5 Shenyang EverBright Pharmaceutical SWOT Analysis
- 10.2.6 Shenyang EverBright Pharmaceutical Recent Developments
- 10.3 Yantai Dongcheng Beifang Pharmaceutical
- 10.3.1 Yantai Dongcheng Beifang Pharmaceutical Basic Information
- 10.3.2 Yantai Dongcheng Beifang Pharmaceutical Chorionic Gonadotrophin for Injection Product Overview
- 10.3.3 Yantai Dongcheng Beifang Pharmaceutical Chorionic Gonadotrophin for Injection Product Market Performance
- 10.3.4 Yantai Dongcheng Beifang Pharmaceutical Business Overview
- 10.3.5 Yantai Dongcheng Beifang Pharmaceutical SWOT Analysis
- 10.3.6 Yantai Dongcheng Beifang Pharmaceutical Recent Developments
- 10.4 Livzon Pharmaceutical Group
- 10.4.1 Livzon Pharmaceutical Group Basic Information
- 10.4.2 Livzon Pharmaceutical Group Chorionic Gonadotrophin for Injection Product Overview
- 10.4.3 Livzon Pharmaceutical Group Chorionic Gonadotrophin for Injection Product Market Performance
- 10.4.4 Livzon Pharmaceutical Group Business Overview
- 10.4.5 Livzon Pharmaceutical Group Recent Developments
- 10.5 Ningbo Renjian Pharmaceutical
- 10.5.1 Ningbo Renjian Pharmaceutical Basic Information
- 10.5.2 Ningbo Renjian Pharmaceutical Chorionic Gonadotrophin for Injection Product Overview
- 10.5.3 Ningbo Renjian Pharmaceutical Chorionic Gonadotrophin for Injection Product Market Performance
- 10.5.4 Ningbo Renjian Pharmaceutical Business Overview
- 10.5.5 Ningbo Renjian Pharmaceutical Recent Developments
- 10.6 Ma'anshan Fengyuan Pharmaceutical
- 10.6.1 Ma'anshan Fengyuan Pharmaceutical Basic Information
- 10.6.2 Ma'anshan Fengyuan Pharmaceutical Chorionic Gonadotrophin for Injection Product Overview
- 10.6.3 Ma'anshan Fengyuan Pharmaceutical Chorionic Gonadotrophin for Injection Product Market Performance
- 10.6.4 Ma'anshan Fengyuan Pharmaceutical Business Overview
- 10.6.5 Ma'anshan Fengyuan Pharmaceutical Recent Developments
- 10.7 Harbin High-Tech Group Baitian'er Pharmaceutical
- 10.7.1 Harbin High-Tech Group Baitian'er Pharmaceutical Basic Information
- 10.7.2 Harbin High-Tech Group Baitian'er Pharmaceutical Chorionic Gonadotrophin for Injection Product Overview
- 10.7.3 Harbin High-Tech Group Baitian'er Pharmaceutical Chorionic Gonadotrophin for Injection Product Market Performance
- 10.7.4 Harbin High-Tech Group Baitian'er Pharmaceutical Business Overview
- 10.7.5 Harbin High-Tech Group Baitian'er Pharmaceutical Recent Developments
- 10.8 Sinopharm
- 10.8.1 Sinopharm Basic Information
- 10.8.2 Sinopharm Chorionic Gonadotrophin for Injection Product Overview
- 10.8.3 Sinopharm Chorionic Gonadotrophin for Injection Product Market Performance
- 10.8.4 Sinopharm Business Overview
- 10.8.5 Sinopharm Recent Developments
- 10.9 Besins Healthcare Benelux
- 10.9.1 Besins Healthcare Benelux Basic Information
- 10.9.2 Besins Healthcare Benelux Chorionic Gonadotrophin for Injection Product Overview
- 10.9.3 Besins Healthcare Benelux Chorionic Gonadotrophin for Injection Product Market Performance
- 10.9.4 Besins Healthcare Benelux Business Overview
- 10.9.5 Besins Healthcare Benelux Recent Developments
- 10.10 Bristol Myers Squibb
- 10.10.1 Bristol Myers Squibb Basic Information
- 10.10.2 Bristol Myers Squibb Chorionic Gonadotrophin for Injection Product Overview
- 10.10.3 Bristol Myers Squibb Chorionic Gonadotrophin for Injection Product Market Performance
- 10.10.4 Bristol Myers Squibb Business Overview
- 10.10.5 Bristol Myers Squibb Recent Developments
- 10.11 Organon
- 10.11.1 Organon Basic Information
- 10.11.2 Organon Chorionic Gonadotrophin for Injection Product Overview
- 10.11.3 Organon Chorionic Gonadotrophin for Injection Product Market Performance
- 10.11.4 Organon Business Overview
- 10.11.5 Organon Recent Developments
- 11 Chorionic Gonadotrophin for Injection Market Forecast by Region
- 11.1 Global Chorionic Gonadotrophin for Injection Market Size Forecast
- 11.2 Global Chorionic Gonadotrophin for Injection Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe Chorionic Gonadotrophin for Injection Market Size Forecast by Country
- 11.2.3 Asia Pacific Chorionic Gonadotrophin for Injection Market Size Forecast by Region
- 11.2.4 South America Chorionic Gonadotrophin for Injection Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of Chorionic Gonadotrophin for Injection by Country
- 12 Forecast Market by Type and by Application (2026-2033)
- 12.1 Global Chorionic Gonadotrophin for Injection Market Forecast by Type (2026-2033)
- 12.1.1 Global Forecasted Sales of Chorionic Gonadotrophin for Injection by Type (2026-2033)
- 12.1.2 Global Chorionic Gonadotrophin for Injection Market Size Forecast by Type (2026-2033)
- 12.1.3 Global Forecasted Price of Chorionic Gonadotrophin for Injection by Type (2026-2033)
- 12.2 Global Chorionic Gonadotrophin for Injection Market Forecast by Application (2026-2033)
- 12.2.1 Global Chorionic Gonadotrophin for Injection Sales (K Units) Forecast by Application
- 12.2.2 Global Chorionic Gonadotrophin for Injection Market Size (M USD) Forecast by Application (2026-2033)
- 13 Conclusion and Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
